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Background and PurposezzSeveral risk scores have been developed to predict mortality in 
intracerebral hemorrhage (ICH). We aimed to systematically determine the performance of 
published prognostic tools.
MethodszzWe searched MEDLINE and EMBASE for prognostic models (published between 
2004 and April 2014) used in predicting early mortality (<6 months) after ICH. We evaluated 
the discrimination performance of the tools through a random-effects meta-analysis of the 
area under the receiver operating characteristic curve (AUC) or c-statistic. We evaluated the 
following components of the study validity: study design, collection of prognostic variables, 
treatment pathways, and missing data.
ResultszzWe identified 11 articles (involving 41,555 patients) reporting on the accuracy of 12 
different tools for predicting mortality in ICH. Most studies were either retrospective or post-
hoc analyses of prospectively collected data; all but one produced validation data. The Hemp-
hill-ICH score had the largest number of validation cohorts (9 studies involving 3,819 pa-
tients) within our systematic review and showed good performance in 4 countries, with a 
pooled AUC of 0.80 [95% confidence interval (CI)=0.77–0.85]. We identified several modified 
versions of the Hemphill-ICH score, with the ICH-Grading Scale (GS) score appearing to be 
the most promising variant, with a pooled AUC across four studies of 0.87 (95% CI=0.84–
0.90). Subgroup testing found statistically significant differences between the AUCs obtained 
in studies involving Hemphill-ICH and ICH-GS scores (p=0.01).
ConclusionszzOur meta-analysis evaluated the performance of 12 ICH prognostic tools and 
found greater supporting evidence for 2 models (Hemphill-ICH and ICH-GS), with generally 
good performance overall.
Key Wordszz stroke, prognostic scores, risk prediction model, mortality.
Prognostic Tools for Early Mortality in Hemorrhagic Stroke: 
Systematic Review and Meta-Analysis
INTRODUCTION
Strokes are an important cause of mortality and morbidity worldwide. The consequences 
of stroke can be severe, leading annually to 5 million deaths and another 5 million people 
being left permanently disabled.1 While hemorrhagic stroke/intracerebral hemorrhage 
(ICH) is less common than ischemic stroke, the prognosis of ICH is substantially worse than 
those conditions with an ischemic etiology. The proportion of stroke patients with ICH was 
14.5% in an Australian study, with a 28-day mortality of 45%, similar to data obtained in 
Europe and the US.2 The threat from ICH appears to be growing (perhaps due to an aging 
population), as indicated by a 47% increase in its incidence and a 20% increase in the num-
ber of deaths during 1990–2010 in the Global Burden Disease Study.3 
Several studies in recent years have therefore focused on deriving and validating prog-
nostic scores for detecting early mortality after an ICH in the acute setting. This is particu-
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larly pertinent given that the risk of a poor outcome is high-
er for ICH than for the other stroke subtypes,4 and the use of 
a prognostic model has been found to confer greater accura-
cy than merely relying on clinical judgment.5 In the absence 
of well-established interventions to reduce deaths from ICH, 
accurate prognostic tools may prove useful for informed 
decision-making in the acute phase of ICH, including the 
options of transferring to intensive care, rehabilitation, and 
palliation. In the research setting, prognostic scores may also 
prove useful for the risk stratification of participants in clini-
cal trials of interventions for ICH.
Published systematic reviews of prognostic models in ICH 
date back at least 10 years,6,7 and the only recent systematic 
review that we are aware of was reported in a conference ab-
stract in 2010, and has not been reported elsewhere in more 
detail.8 A comprehensive update seems timely given 1) the 
recent publication of new studies that have evaluated differ-
ent prognostic scores and 2) the absence of a unified system 
that is accepted in routine clinical practice. 
Hence, in the present study we aimed to synthesize the re-
cent evidence on prognostic tools in patients presenting with 
ICH, and to determine the comparative performances of dif-
ferent scores.
METHODS
Eligibility criteria
We selected studies that collected clinical variables (or sets 
of these variables) used to calculate risk scores predicting 
early mortality (<6 months) in adult patients at the time of 
presentation with ICH. We stipulated that studies had to 
have a sample size of >100 participants, with the main focus 
being on those presenting with primary ICH. Our specific 
interest was the reporting of the discrimination ability of the 
tool, measured based on the area under the receiver operat-
ing characteristic curve (AUC) or c-statistic. We aimed to 
base our systematic review on more-up-to-date evidence, and 
as such restricted our selection to the past decade; that is, 
studies published from 2004 to April 2014.
We excluded studies that were aimed solely at determin-
ing correlations between mortality and single laboratory 
(e.g., albumin or troponin) or radiological (e.g., lesion vol-
ume) variables. We did not include studies of only function-
al outcomes. Since our main focus was on stroke patients 
presenting to healthcare facilities and we wanted to maxi-
mize the generalizability of the findings, we excluded studies 
involving narrow subgroups of ICH patients who had been 
deemed to require admission to intensive care. We also ex-
cluded studies that focused on mortality in specific subsets of 
patients (e.g., following certain interventions such as throm-
bolysis) or those that specifically evaluated the prognosis of 
a stroke affecting a particular brain area (e.g., basal ganglia). 
Search strategy
We searched MEDLINE and EMBASE (in April 2014, using 
the OvidSP interface) using the search terms listed in Sup-
plementary (in the online-only Data Supplement), without 
any language restriction. We also checked the bibliographies 
of the included studies for other potentially suitable studies.
Study selection and data extraction
Study screening and data extraction were performed by pairs 
of reviewers (selected from K.M., C.S.K., K.P., and Y.K.L.) 
who independently scanned all titles and abstracts for po-
tentially relevant articles, whose full-text versions were re-
trieved for further detailed evaluation. Any uncertainties 
and discrepancies were resolved through discussion and with 
a third reviewer. We also contacted authors if any aspects of 
their articles required further clarification. 
We used a standardized form for data collection that in-
cluded details of the setting and date of the study, geographi-
cal location, selection criteria, and other characteristics of the 
participants, and outcome measures.
Assessment of study validity
Study validity was assessed by pairs of reviewers indepen-
dently checking whether there was clear reporting of the 
times of patient assessments, missing or incomplete data, use 
of standardized treatment protocols, and whether the study 
involved a derivation or validation cohort. 
Data analysis
Statistical analysis was conducted by an experienced meta-
analyst (Y.K.L.) using Cochrane Collaboration RevMan 5.3 
software (Nordic Cochrane Centre, Kobenhavn, Denmark).
We chose to base our analysis on the AUC or c-statistic 
since these are equivalent measures of the discrimination 
ability for binary outcomes.9 In the present context the dis-
crimination ability refers to how well the model separates 
patients who subsequently die from those who are survi-
vors. For studies that investigated both derivation and vali-
dation components, we chose to analyze data relating to the 
validation portion. If different mortality time points were 
used in a particular study, we used 30 days as the first choice 
and inpatient mortality as the second choice, and where nei-
ther was available we accepted a time point of <6 months for 
analysis. If multiple AUC values were available for a partic-
ular prognostic tool, we calculated a weighted pooled aver-
age using a random-effects inverse-variance meta-analysis. 
If the AUCs were listed without standard errors, we deter-
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mined these values through Hanley’s method and the 95% 
confidence intervals (CIs).10
We assessed heterogeneity using the I2 statistic and by vi-
sual inspection of Forest plots. The performance of the prog-
nostic score was judged according to the following AUC 
thresholds that have been described by other researchers: 
excellent (AUC ≥0.90), good (AUC ≥0.80 and <0.90), fair 
(AUC ≥0.70 and <0.80), and poor (AUC <0.70).11
RESULTS
We selected 11 relevant studies from 2,603 articles identified 
by searching the electronic databases (the flow chart of study 
selection is shown in Fig. 1).4,5,12-20 The characteristics and 
results of the included studies are reported in Table 1, and 
our appraisal of study validity is presented in Table 2. Vari-
ables required for the calculation of each prognostic model 
are listed in Table 3.
The included studies involved 41,555 participants (sample 
sizes ranged from 154 to 37,509 in the 11 studies) with a 
mean age of 67 years, while 55% of them were male. Six of 
the studies addressed the 30-day mortality, three addressed 
inpatient mortality,13,19,20 and two addressed mortality at 90 
or 120 days.4,5 Four studies recruited patients from two or 
more healthcare sites.4,5,12,19 The geographical locations were 
diverse, and included North America, Europe, Mexico, and 
East Asia. Data from the study performed in Taiwan were 
reported in two separate articles, with Hemphill-ICH scores 
available from one and ICH-Grading Scale (GS) scores from 
the other, with substantial overlap in the included patients.16,21
Validity assessment 
Most of the studies had a retrospective design, or performed 
post-hoc analyses of prospectively collected clinical data. We 
were able to determine that the prognostic variables were 
collected early in the course of the presentation in five stud-
ies.5,16-19 Treatment pathways were seldom reported, with 
only one study explicitly stating that all participants received 
similar care.5 Details on losses to follow-up or missing data 
were reported for seven studies (Table 2).4,5,12,14,15,17,18 Eight 
studies aimed to perform model validation, two had a mixed 
derivation-validation design,18,20 and one that had a purely 
derivation design.13 We considered the findings of these deri-
vation studies to be less robust than those that had been sub-
mitted for external validation.
Quantitative comparison of AUC 
We were able to evaluate the following prognostic models in 
the comparative quantitative analysis: Hemphill-ICH22 (nine 
cohorts)4,5,12,14-18,20 and ICH-GS (four cohorts).4,15,16,18 
The AUCs from individual studies and the pooled mean 
AUCs across studies are shown in Fig. 2. 
Hemphill-ICH score
The predictive accuracy of the Hemphill-ICH model for 
mortality has been evaluated in 9 cohorts comprising 3,819 
participants worldwide.4,5,12,14-18,20 Point estimates of the AUC 
ranged from 0.72 to 0.88, with a weighted pooled average 
of 0.80 (95% CI=0.77–0.85) across all studies. Subgroup 
evaluation according to the mortality time point found that 
data from six cohorts were for the 30-day mortality (pooled 
AUC=0.81, 95% CI=0.76–0.86 ),12,14-18 while two were for the 
90- or 120-day mortality (pooled AUC=0.79, 95% CI=0.70–
0.88).4,5 When we excluded the study with the lowest 30-day 
mortality rate, the overall AUC remained good at 0.82 (95% 
CI=0.78–0.85). 
We conducted subgroup analyses looking at the prognos-
tic value of the Hemphill-ICH model according to study de-
sign and patient characteristics (e.g., age and geographical 
location). We found that Hemphill-ICH scores generally per-
formed well across different subgroups (Fig. 3), but there 
was a possible slight decrease in performance in those stud-
ies conducted outside of North America and Europe, or in 
those where the participants were on average younger than 
70 years. 
ICH-GS score
The performance of the ICH-GS score in predicting mortali-
ty has been evaluated in four cohorts comprising participants 
in the US, Spain, Taiwan, and the UK. Point estimates of the 
AUC ranged from 0.74 to 0.88, with a weighted pooled aver-
Fig. 1. Flow chart of study selection. AUC: area under receiver oper-
ating characteristic curve.
Titles and abstracts for screening from search: 
2,603 after deduplication
Detailed checking of full-test versions 
of potentially eligible articles (n=41)
Excluded articles that clearly did not 
meet inclusion criteria (n=2,562)
Excluded (n=30):
Mainly ischaemic stroke: 18
Did not report AUC or outcome of 
interest: 11
Intensive care patients only: 1
Total number of studies included in systematic 
review: 11
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age of 0.87 (95% CI=0.84–0.90).4,15,16,18
Hemphill-ICH versus ICH-GS scores
An overall comparison of the two subgroups using the 
Hemphill-ICH and ICH-GS scores showed that the AUC 
differed significantly (p=0.01) between these two subgroups, 
with the ICH-GS score exhibiting better overall discrimina-
tion performance (Fig. 2). We also assessed four studies that 
evaluated both the Hemphill-ICH and ICH-GS scores in 
the same sample of participants.4,15,16,18 The greatest difference 
in the comparative predictive accuracies of the Hemphill-
ICH and ICH-GS models was seen in the cohort of Garrett 
et al.,4 with a reported difference of 0.14 in the AUC, favoring 
the ICH-GS model. In contrast, the other three studies dem-
onstrated far smaller absolute differences in AUC, with an 
average difference of 0.03 that was also in favor of the ICH-
GS model.
Get With The Guidelines (GWTG) model with or without 
National Institutes of Health Stroke Scale (NIHSS)
Only one study analyzed the performance of the GWTG 
score for predicting inpatient mortality,19 that study enrolled 
37,509 participants in US and Canada. The GWTG alone 
(based on age, vascular risk factors, comorbid conditions, 
and mode of arrival at the hospital) does not require a de-
tailed clinical examination or neuroimaging, but in that 
study it demonstrated a relatively poor predictive accuracy 
with an AUC of 0.66. However, combining the GWTG mod-
el with the NIHSS (in 10,352 participants) resulted in a mark-
edly improved pooled AUC of 0.82.
Glasgow Coma Scale (GCS)
We identified only one recent study that involved a prognos-
tic validation of the GCS.15 That study recruited 1,364 partic-
ipants in the UK and found an AUC of 0.87 (95% CI=0.85–
0.89), which was similar to the AUC values obtained by 
applying the Hemphill-ICH and ICH-GS models to the same 
participants.
Functional outcome risk stratification scale (FUNC)
Garrett et al.4 validated the prognostic accuracy of the FUNC 
score in 366 patients in the US, and found an AUC of 0.87 
(95% CI=0.83–0.90) for 90-day mortality. The AUC for the 
FUNC indicated similarly good predictive accuracy to that 
reported with the ICH-GS score in the same participants, 
whereas the Hemphill-ICH score only exhibited fair perfor-
mance in that cohort.
Essen-ICH score
The Essen-ICH score was validated in 1 study involving 371 Ta
bl
e 
2.
 V
al
id
ity
 a
ss
es
sm
en
t o
f i
nc
lu
de
d 
st
ud
ie
s
St
ud
y 
ID
W
as
 t
he
 in
de
x/
sc
or
e 
ob
ta
in
ed
 e
ar
ly
 in
 t
he
 
pr
es
en
ta
tio
n 
co
ur
se
?
Di
d 
au
th
or
s 
gi
ve
 n
um
be
rs
 
of
 p
at
ie
nt
s 
lo
st
 t
o 
fo
llo
w
-u
p 
or
 w
ith
dr
aw
al
s, 
an
d 
th
e 
re
as
on
s?
Di
d 
au
th
or
s 
st
at
e 
if 
th
e 
pa
tie
nt
s 
w
er
e 
tr
ea
te
d 
on
 
a 
st
an
da
rd
ize
d 
or
 s
im
ila
r c
ar
e 
pa
th
w
ay
?
Va
lid
at
io
n 
st
ud
y
Am
ou
nt
 o
f 
m
iss
in
g 
da
ta
Cl
ar
ke
 2
00
41
2
N
o
Ye
s
N
o
Ye
s
4 
pa
tie
nt
s 
w
ith
 n
o 
fo
llo
w
-u
p
G
ar
re
tt
 2
01
34
N
o
Ye
s
N
o
Ye
s
31
 p
at
ie
nt
s 
w
ith
 n
o 
fo
llo
w
-u
p
Li
 2
01
11
3
N
o
N
o
N
o
N
o
M
at
ch
et
t 2
00
71
4
N
o
Ye
s
N
o
Ye
s
66
 p
at
ie
nt
s 
w
ith
 m
iss
in
g 
da
ta
Pa
rr
y-
Jo
ne
s 
20
13
15
N
o
Ye
s
N
o
Ye
s
13
 p
at
ie
nt
s 
co
ul
d 
no
t b
e 
tr
ac
ed
Pe
ng
 2
01
01
6  a
nd
 C
hu
an
g 
20
09
21
Ye
s
N
o
N
o
Ye
s
Ro
m
an
o 
20
07
17
Ye
s
Ye
s
N
o
Ye
s
7 
pa
tie
nt
s 
ex
cl
ud
ed
Ru
iz
-S
an
do
va
l 2
00
71
8
Ye
s
Ye
s
N
o
De
riv
at
io
n 
of
 IC
H
-G
S
68
 p
at
ie
nt
s 
w
ith
 n
o 
fo
llo
w
-u
p 
at
 3
0 
da
ys
Sm
ith
 2
01
31
9
Ye
s
N
o
N
o
Ye
s
Ta
ka
ha
sh
i 2
00
62
0
N
o
N
o
N
o
De
riv
at
io
n 
of
 C
AR
T
W
ei
m
ar
 2
00
65
Ye
s
Ye
s
Ye
s
Ye
s
75
 p
at
ie
nt
s 
w
ith
 n
o 
fo
llo
w
-u
p
CA
RT
: c
la
ss
ifi
ca
tio
n 
an
d 
re
gr
es
sio
n 
tr
ee
s, 
IC
H
-G
S:
 in
tr
ac
er
eb
ra
l h
em
or
rh
ag
e-
G
ra
di
ng
 S
ca
le
.
6  J Clin Neurol 2015
Predicting Early Mortality in Hemorrhagic StrokeJCN
German patients.5 The AUC of 0.83 (95% CI=0.78–0.88) 
for the Essen-ICH model was similar to those obtained when 
applying the Hemphill-ICH and Cheung-ICH models to the 
same sample of patients.
Other prognostic models
We identified data for two prognostic tools [classification 
and regression trees (CART) and ICH Index] that have yet 
to be validated but which showed good predictive value 
(AUCs of 0.86 and 0.92, respectively) during derivation.13,20 
The CART model is based only on three variables—size of 
hemorrhage, age, and score on the Japan Coma Scale20—
whereas the ICH Index was constructed based on age, GCS 
score, glucose level, and white cell count but without the use 
of neuroimaging.13
DISCUSSION
ICH is associated with the highest morbidity and mortality 
of all types of stroke. We have systematically evaluated re-
cent data obtained by applying several models to predict 
mortality in ICH, and found the Hemphill-ICH score to 
have the broadest evidence base. This score has exhibited 
generally consistent predictive accuracy throughout several 
studies worldwide covering thousands of patients in eight 
countries (China, Japan, Germany, the US, Mexico, Argen-
Table 3. Variables required for estimating the prognostic score
Predictor Hemphill-ICH Essen-ICH ICH-GS FUNC
Age, years 
≥80=1
<80=0
<60=0
60–69=1
70–79=2
≥80=3
<45=1
45–64=2
≥65=3
<70=2
70–79=1
≥80=0 
Pre-ICH cognitive impairment - -
No=1
Yes=0
GCS score
3 or 4=2
5–12=1
13–15=0
-
13–15=1
9–12=2
3–8=3
≥9=2
≤8=0
Hemorrhage volume, mL
≥30=1
<30=0 -
Supratentorial
<40=1
40–70=2
>70=3
Infratentorial 
<10=1
10–20=2
>20=3
<30=4
30–60=2
>60=0
ICH location 
Infratentorial 
Yes=1
No=0
-
Supratentorial=1
Infratentorial=2 
Lobar=2
Deep=1
Infratentorial=0
Extension into ventricles  
Yes=1
No=0 -
Yes=1
No=0
-
NIHSS neurological examination score
0–5=0
6–10=1
11–15=2
16–20=3
>20 or coma=4
- -
NIHSS level of consciousness 
Alert=0
Drowsy=1
Stupor=2
Coma=3
Maximum score 6 10 13 11
FUNC: functional outcome risk stratification scale, GCS: Glasgow Coma Scale, ICH: intracerebral hemorrhage, NIHSS: National Institutes of Health 
Stroke Scale.
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tina, Taiwan, and the UK). Although the Hemphill-ICH 
score was introduced more than 10 years ago, it is not yet 
widely adopted in clinical practice. Instead, we found nu-
merous instances where researchers have modified the 
Hemphill-ICH score to try and improve its predictive accu-
racy, with varying degrees of success. The availability of sev-
eral versions of the ICH score can seem bewildering—an 
important finding of our systematic review is that the ICH-
GS score seems the one most likely to offer some consistent 
advantage over the original Hemphill-ICH score. The slightly 
improved performance when using the ICH-GS score may 
stem from the greater detail with which the site and size of 
the hemorrhage are considered, as well as the inclusion of 
additional age categories (Table 3). However, we recognize 
that these changes may make the ICH-GS score more com-
plicated to calculate in practice. 
We also identified variations in the complexity and in the 
requirement for specialist knowledge when using some of 
the tools (e.g., reproducibility when interpreting hemorrhage 
volume on CT scans and calculation of subscores such as the 
NIHSS). The need for specialist expertise may prove to be a 
barrier in emergency departments where clinicians may pre-
fer a tool that is simply based on clinical variables, such as 
the GCS and the (as yet unvalidated) ICH Index.13,15 Indeed, 
Parry-Jones et al.15 found that the AUC of the GCS score was 
as good as that of the ICH score in a UK validation cohort, 
but we were unable to identify other recent data sets for con-
firming the generalizability of these findings. This is an in-
teresting point, since the GCS score can be rapidly assessed 
at the initial presentation and does not require specialist neu-
rological imaging procedures or expertise. Further valida-
tion studies of the GCS score and ICH Index would be useful, 
particularly in resource-poor areas or as initial triage tools 
in nonspecialized healthcare facilities.
Several prognostic models are associated with additional 
complexity due to them requiring a detailed neurological 
examination to estimate the NIHSS score.5,19 For instance, 
the GWTG model exhibited a poor AUC score (<0.7) when 
it was applied alone, but this improved to a good AUC score 
when it was combined with the NIHSS.19 Having to use both 
GWTG and NIHSS scores together may prove too labori-
ous for clinicians, particularly given that dedicated online 
training is required for calculating the NIHSS score.23 The 
Essen-ICH score also requires calculation of the NIHSS 
score and this might equally limit its acceptability, particu-
larly given that a previous study found no marked improve-
ment in AUC over that for the Hemphill-ICH score.5
Most of the available studies have not addressed the ac-
ceptability and uptake of current prognostic scores in the 
day-to-day management of stroke patients. While the avail-
ability of a prediction rule with good performance is an im-
portant prerequisite, patients will not benefit from the pro-
Study or Subgroup Discriminant ability Weight
AUC
IV, random, 95% CI
1.1.1 Hemphill-ICH
Clarke 200412 Good 11.3% 0.88 (0.83, 0.93)
Garrett 20134 Fair 11.5% 0.74 (0.70, 0.78)
Matchett 200614 Good 10.2% 0.81 (0.76, 0.88)
Parry-Jones 201315 Good 12.9% 0.86 (0.84, 0.88)
Peng 201016 and Chuang 200921 Fair 11.4% 0.72 (0.68, 0.76)
Romano 200717 Fair 9.7% 0.74 (0.68, 0.80)
Ruiz-Sandoval 200718 Good 11.4% 0.83 (0.79, 0.88)
Takahashi 200620 Good 10.2% 0.83 (0.77, 0.89)
Weimar 20065 Good 11.3% 0.83 (0.78, 0.88)
Subtotal (95% CI) 100.0% 0.80 (0.77, 0.85)
Heterogeneity: Tau2=0.00; chi2=63.04, df=8 (p<0.00001); I2=87%
1.1.2 ICH-GS
Garrett 20134 Good 28.1% 0.88 (0.85, 0.92)
Parry-Jones 201315 Good 38.4% 0.87 (0.85 0.89)
Peng 201016 and Chuang 200921 Fair 6.4% 0.74 (0.65, 0.84)
Ruiz-Sandoval 200718 Good 27.1% 0.88 (0.85, 0.92)
Subtotal (95% CI) 100.0% 0.87 (0.84, 0.90)
Heterogeneity: Tau2=0.00; chi2=7.42, df=3 (p<0.06); I2=83.9%
Test for subgroup differences: Chi2=6.22, df=1 (p=0.01), I2=83.9% 0.5              0.7                 1
Fig. 2. Meta-analysis of the areas under the receiver operating characteristic curve (AUC) for various prognostic models. CI: confidence interval, 
ICH: intracerebral hemorrhage.
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Study or subgroup Weight
AUC
IV, random, 95% CI
1.3.1 Europe and North America
Clarke 200412 16.9% 0.88 (0.83, 0.93)
Garrett 20134 17.2% 0.74 (0.70, 0.78)
Matchett 200614 15.1% 0.81 (0.76, 0.88)
Parry-Jones 201315 19.5% 0.86 (0.84, 0.88)
Romano 200717 14.4% 0.74 (0.68, 0.80)
Weimar 20065 16.9% 0.83 (0.78, 0.88)
Subtotal (95% CI) 100.0% 0.81 (0.77, 0.86)
Heterogeneity: Tau2=0.00; chi2=37.30, df=5 (p<0.00001); I2=87%
1.3.2 Asia and South America
Peng 201016 and Chuang 200921 34.2% 0.72 (0.68, 0.76)
Ruiz-Sandoval 200718 34.3% 0.83 (0.79, 0.88)
Takahashi 2007 31.5% 0.83 (0.77, 0.89)
Subtotal (95% CI) 100.0% 0.79 (0.72, 0.87)
Heterogeneity: Tau2=0.01; chi2=15.76, df=2 (p<0.0004); I2=87%
1.3.3 Sample size >250 participants
Garrett 20134 16.7% 0.74 (0.70, 0.78)
Parry-Jones 201315 18.6% 0.86 (0.84, 0.88)
Peng 201016 and Chuang 200921 16.6% 0.72 (0.68, 0.76)
Ruiz-Sandoval 200718 16.7% 0.83 (0.79, 0.88)
Takahashi 200620 15.0% 0.83 (0.77, 0.89)
Weimar 20065 16.5% 0.83 (0.78, 0.88)
Subtotal (95% CI) 100.0% 0.80 (0.75, 0.85)
Heterogeneity: Tau2=0.01; chi2=50.51, df=5 (p<0.00001); I2=90%
1.3.4 Prospective studies
Parry-Jones 201315 31.6% 0.86 (0.84, 0.88)
Romano 200717 18.9% 0.74 (0.68, 0.80)
Ruiz-Sandoval 200718 25.0% 0.83 (0.79, 0.88)
Weimar 20065 24.4% 0.83 (0.78, 0.88)
Subtotal (95% CI) 100.0% 0.82 (0.78, 0.87)
Heterogeneity: Tau2=0.00; chi2=13.92, df=3 (p<0.003); I2=78%
1.3.5 Mean or median age 70 years and above
Clarke 200412 22.3% 0.88 (0.83, 0.93)
Matchett 200614 14.0% 0.81 (0.76, 0.88)
Parry-Jones 201315 63.8% 0.86 (0.84, 0.88)
Subtotal (95% CI) 100.0% 0.86 (0.83, 0.88)
Heterogeneity: Tau2=0.00; chi2=2.72, df=2 (p<0.26); I2=27%
1.3.6 Mean or median age below 70 years
Garrett 20134 25.2% 0.74 (0.70, 0.78)
Peng 201016 and Chuang 200921 25.0% 0.72 (0.68, 0.76)
Ruiz-Sandoval 200718 25.1% 0.83 (0.79, 0.88)
Weimar 20065 24.8% 0.83 (0.78, 0.88)
Subtotal (95% CI) 100.0% 0.78 (0.72, 0.84)
Heterogeneity: Tau2=0.00; chi2=21.10, df=3 (p<0.0001); I2=86%
0.5                 0.7                     1
Fig. 3. Subgroup analyses of the Hemphill-intracerebral hemorrhage model according to the study design and characteristics of participants. CI: 
confidence interval. 
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liferation of prognostic scoring models if their uptake and 
implementation is patchy. It is important to determine what 
clinicians want or expect from a score and what factors would 
facilitate their use of it. Furthermore, the expectations of pa-
tients and their relatives also need to be considered, such as 
by determining whether prognostic scoring is acceptable and 
useful to interactions (as compared to relying on clinical 
judgment). Shared decision-making is pivotal in modern 
medicine, but our systematic review shows that none of the 
current prognostic models are able to achieve excellent per-
formance, and thus the acceptability of imperfect results 
needs to be assessed. We note that a survey found that 96% 
of emergency physicians were prepared to use a prognostic 
tool for stroke or death in patients with transient ischemic 
attacks, but only if the tool achieved a sensitivity of >97%.24
Our systematic review has limitations. We focused only 
on larger studies (>100 participants) published during the 
last 10 years, and emphasized overall mortality—because of 
the high rate of early mortality in ICH—rather than the 
functional outcome. Most of the included studies had a ret-
rospective design or were post-hoc analyses of prospectively 
collected clinical data, and we did not categorize the studies 
into high- and low-quality subgroups. We selected published 
studies that used the AUC or c-statistic as their primary 
measure, and it is possible that studies that found poor per-
formance have not been reported on.
The strengths of our systematic review are that we con-
ducted an exhaustive and up-to-date search of the current 
evidence, accompanied by critical appraisal and quantitative 
data analysis. To the best of our knowledge, none of the pre-
vious systematic reviews have performed a meta-analysis of 
discrimination ability. We have summarized the evidence for 
the relative performances from comprehensive data sets to 
help guide stroke researchers and clinicians as to which score 
to use, further develop, or test. 
A key question to consider is whether we genuinely need 
further research that might involve only minor modifications 
to the Hemphill-ICH model, and which may not provide 
more than minor incremental benefits to the clinical accura-
cy. The proliferation of variants of the Hemphill-ICH model 
may simply cause greater confusion amongst clinicians and 
thereby have a detrimental effect on clinical implementation. 
Future studies should focus on the factors that influence the 
acceptability and adoption of scoring systems, and whether 
their implementation leads to consistent improvements in 
patient care relative to simply using subjective clinical judg-
ment. 
In conclusions, we have highlighted several prognostic 
scores that exhibit good performance in ICH, the front run-
ners being the Hemphill-ICH score and the ICH-GS vari-
ant, which we believe can usefully guide clinicians in mak-
ing better-informed treatment decisions. Although further 
validation studies are needed, the GCS and ICH Index may 
also be reasonable options in situations where simple and 
rapid clinical assessment is needed before neuroimaging re-
sults become available, such as during triage when a patient 
initially presents to a healthcare facility.
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